Pharmaceutical manufacturer MSD on Thursday called for African countries to invest in better healthcare data, arguing it was vital for assessing the market opportunities for new drugs and diagnostics.
MSD Africa managing director Priya Agrawal said a lack of incidence data – which measures the rate at which new cases occur – was holding back investment decisions...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.